Combined Systems for Brain Function Assessment

Electrical Geodesics, Inc., a leading neurodiagnostic medical technology company is to supply GES 400 systems for use with ElMindA’s Brain Network Activation (BNA™) platform.

ElMindA is a US and Israel-based company that is engaged in the development, marketing, and distribution of the BNA™ platform, an analysis system that received FDA clearance in 2014 for the assessment of brain function in 14 to 24-years old.  Combining EGI’s non-invasive, multi-channel EEG technology with ElMindA’s signal processing and analysis algorithms, BNA™ measures patterns of brain networks activated during specific brain processes and delivers both quantitative and qualitative insights into brain function and dysfunction.  Using its proprietary database with more than 8,000 datasets, BNA™ can be used by physicians to potentially help identify and manage neurological disorders. 

Don Tucker, CEO of EGI, commented:  “We have worked with ElMindA over a number of years and are pleased that their research efforts have led to the BNA™ system receiving FDA clearance.  ElMindA recognizes the need for the precision dense array EEG provides to enable objective assessment of brain disorders and injuries.  We believe that by working together, we can bring both our technologies into wider clinical use and drive revenues for both companies.”

Under the agreement, EGI agrees to supply and support ElMindA's customers purchasing the BNA™ analysis system with its leading GES 400 dense array EEG systems on pre-determined terms.

“EGI delivers the quality of dEEG data required to support the BNA™ platform,” said Ronen Gadot, CEO of ElMindA. “We are pleased to collaborate with a partner that offers cutting edge, reliable technology, allowing physicians to acquire the level of data needed to deliver BNA™ test reports in a timely and cost-effective manner.  The importance of this technology has been recognized by the Chief Science Officer of Israel, who has granted funding to further develop the BNA™ system for both diagnostic and therapeutic applications.”